Eliem Therapeutics Inc
NASDAQ:ELYM 2:02:34 PM EDT
Earnings Announcements
Eliem Therapeutics Reports Second Quarter Financial Results
Published: 09/13/2021 20:21 GMT
Eliem Therapeutics Inc (ELYM) - Eliem Therapeutics Reports Second Quarter Financial Results.
Eliem Therapeutics - Qtrly Loss per Share $3.11.
Eliem Therapeutics Inc - Cash Was $99.5 Million As of June 30, 2021.
Eliem Therapeutics - Qtrly Loss per Share $3.11.
Eliem Therapeutics Inc - Cash Was $99.5 Million As of June 30, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.94
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.60
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.94
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.60
More details on our Analysts Page.